<DOC>
	<DOCNO>NCT00383188</DOCNO>
	<brief_summary>Investigating safety tolerability p38 inhibitor monotherapy subject fail least 1 DMARD .</brief_summary>
	<brief_title>An Oral p38 Inhibitor Investigating Safety , Efficacy , And PK In Subjects With Active Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Diagnosed RA fail least 1 DMARD therapy Any inflammatory arthritis significant history acute chronic infection immunomodulatory etiology</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Arthritis , Rheumatoid</keyword>
</DOC>